Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Hepatocellular | 9 | 2023 | 2331 | 2.050 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 11 | 2025 | 520 | 2.030 |
Why?
|
Duodenoscopes | 3 | 2024 | 43 | 1.930 |
Why?
|
Jejunostomy | 2 | 2024 | 61 | 1.840 |
Why?
|
Liver Neoplasms | 11 | 2023 | 4360 | 1.770 |
Why?
|
Pancreatic Neoplasms | 16 | 2024 | 5443 | 1.720 |
Why?
|
Gastric Balloon | 3 | 2021 | 36 | 1.660 |
Why?
|
Ampulla of Vater | 3 | 2024 | 150 | 1.530 |
Why?
|
Clostridium Infections | 4 | 2023 | 560 | 1.380 |
Why?
|
Enteral Nutrition | 3 | 2024 | 804 | 1.350 |
Why?
|
Common Bile Duct Neoplasms | 2 | 2021 | 121 | 1.330 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2021 | 219 | 1.250 |
Why?
|
Colonic Polyps | 5 | 2024 | 557 | 1.220 |
Why?
|
Obesity, Morbid | 5 | 2022 | 1306 | 1.200 |
Why?
|
Endoscopy, Gastrointestinal | 7 | 2024 | 887 | 1.190 |
Why?
|
Bariatric Surgery | 4 | 2024 | 1012 | 1.110 |
Why?
|
Pancreatitis | 6 | 2024 | 1087 | 1.070 |
Why?
|
Pancreatitis, Chronic | 3 | 2024 | 282 | 1.070 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2022 | 959 | 1.030 |
Why?
|
Bile Duct Neoplasms | 3 | 2021 | 616 | 0.980 |
Why?
|
Disposable Equipment | 2 | 2024 | 46 | 0.970 |
Why?
|
Equipment Failure | 6 | 2024 | 585 | 0.960 |
Why?
|
Endoscopy | 6 | 2024 | 1856 | 0.920 |
Why?
|
Colorectal Neoplasms | 9 | 2024 | 6969 | 0.910 |
Why?
|
Cholangitis | 2 | 2024 | 110 | 0.860 |
Why?
|
Intubation, Gastrointestinal | 2 | 2024 | 166 | 0.840 |
Why?
|
Proctitis | 1 | 2022 | 40 | 0.830 |
Why?
|
Gastrointestinal Hemorrhage | 8 | 2025 | 1126 | 0.820 |
Why?
|
Pancreatic Pseudocyst | 1 | 2022 | 112 | 0.810 |
Why?
|
Colonoscopy | 8 | 2024 | 1412 | 0.770 |
Why?
|
Esophagoplasty | 1 | 2021 | 48 | 0.770 |
Why?
|
Cholelithiasis | 1 | 2023 | 408 | 0.770 |
Why?
|
Hemostasis, Endoscopic | 4 | 2023 | 42 | 0.760 |
Why?
|
Duodenal Neoplasms | 1 | 2021 | 114 | 0.720 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2020 | 51 | 0.710 |
Why?
|
Gastroesophageal Reflux | 4 | 2024 | 835 | 0.700 |
Why?
|
Attitude to Health | 2 | 2019 | 2025 | 0.670 |
Why?
|
Bone Diseases, Metabolic | 1 | 2023 | 411 | 0.660 |
Why?
|
Enema | 1 | 2020 | 141 | 0.660 |
Why?
|
Carcinoid Tumor | 1 | 2021 | 223 | 0.650 |
Why?
|
Stents | 5 | 2024 | 3201 | 0.640 |
Why?
|
Gastroparesis | 1 | 2021 | 143 | 0.640 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2022 | 495 | 0.640 |
Why?
|
Early Detection of Cancer | 5 | 2023 | 3236 | 0.610 |
Why?
|
Endosonography | 6 | 2024 | 622 | 0.610 |
Why?
|
Liver Cirrhosis | 5 | 2023 | 1957 | 0.610 |
Why?
|
Colonic Pouches | 1 | 2019 | 122 | 0.600 |
Why?
|
Stomach Neoplasms | 4 | 2024 | 1481 | 0.600 |
Why?
|
Humans | 121 | 2025 | 768298 | 0.580 |
Why?
|
Proctocolectomy, Restorative | 1 | 2019 | 191 | 0.580 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 562 | 0.570 |
Why?
|
Gastroenterology | 1 | 2024 | 589 | 0.560 |
Why?
|
Endoscopes | 1 | 2018 | 169 | 0.550 |
Why?
|
Databases, Factual | 11 | 2024 | 8072 | 0.550 |
Why?
|
Incidence | 13 | 2025 | 21544 | 0.520 |
Why?
|
Adenoma | 3 | 2021 | 2163 | 0.520 |
Why?
|
Appendicitis | 1 | 2022 | 689 | 0.510 |
Why?
|
SEER Program | 5 | 2021 | 1474 | 0.500 |
Why?
|
Electric Stimulation Therapy | 1 | 2021 | 636 | 0.490 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 308 | 0.480 |
Why?
|
Liver | 2 | 2021 | 7570 | 0.460 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 796 | 0.460 |
Why?
|
Osteoporosis | 1 | 2023 | 1606 | 0.440 |
Why?
|
Choledocholithiasis | 2 | 2024 | 50 | 0.440 |
Why?
|
Esophageal Neoplasms | 2 | 2024 | 1675 | 0.430 |
Why?
|
Trust | 1 | 2018 | 532 | 0.420 |
Why?
|
Adenocarcinoma | 3 | 2024 | 6404 | 0.420 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2021 | 1756 | 0.410 |
Why?
|
Hepatitis C | 1 | 2023 | 1593 | 0.410 |
Why?
|
Precancerous Conditions | 1 | 2019 | 984 | 0.410 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1185 | 0.400 |
Why?
|
Minority Groups | 1 | 2019 | 1215 | 0.390 |
Why?
|
Hemorrhage | 2 | 2024 | 3461 | 0.390 |
Why?
|
Treatment Outcome | 25 | 2024 | 65365 | 0.370 |
Why?
|
Biopsy | 3 | 2024 | 6808 | 0.370 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1371 | 0.360 |
Why?
|
United States | 17 | 2025 | 73144 | 0.350 |
Why?
|
Gastric Bypass | 3 | 2024 | 829 | 0.350 |
Why?
|
Gallstones | 2 | 2024 | 285 | 0.350 |
Why?
|
Surgical Instruments | 2 | 2024 | 385 | 0.340 |
Why?
|
Cross Infection | 1 | 2019 | 1422 | 0.340 |
Why?
|
Occult Blood | 2 | 2022 | 199 | 0.340 |
Why?
|
Hemostatics | 2 | 2023 | 246 | 0.330 |
Why?
|
Esophageal Achalasia | 2 | 2021 | 98 | 0.330 |
Why?
|
Pancreas | 5 | 2024 | 1701 | 0.330 |
Why?
|
Postoperative Complications | 6 | 2025 | 15854 | 0.330 |
Why?
|
Motivation | 1 | 2019 | 2029 | 0.330 |
Why?
|
Population Surveillance | 1 | 2020 | 2598 | 0.330 |
Why?
|
Gastrectomy | 3 | 2024 | 696 | 0.320 |
Why?
|
Hospitals | 2 | 2020 | 3905 | 0.320 |
Why?
|
United States Food and Drug Administration | 5 | 2024 | 1672 | 0.300 |
Why?
|
Registries | 3 | 2021 | 8378 | 0.300 |
Why?
|
Barrett Esophagus | 2 | 2024 | 494 | 0.300 |
Why?
|
Inpatients | 4 | 2025 | 2569 | 0.300 |
Why?
|
Ophthalmology | 1 | 2014 | 560 | 0.290 |
Why?
|
Pancreatic Cyst | 2 | 2021 | 369 | 0.290 |
Why?
|
Self Report | 1 | 2019 | 3766 | 0.290 |
Why?
|
Sphincterotomy, Endoscopic | 3 | 2021 | 44 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9433 | 0.290 |
Why?
|
Coronary Disease | 1 | 2021 | 5926 | 0.270 |
Why?
|
Retrospective Studies | 15 | 2025 | 81768 | 0.270 |
Why?
|
Coronary Vessels | 1 | 2018 | 3125 | 0.270 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2830 | 0.270 |
Why?
|
New York | 2 | 2019 | 884 | 0.260 |
Why?
|
Male | 32 | 2025 | 364870 | 0.260 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11254 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3230 | 0.250 |
Why?
|
Demography | 2 | 2019 | 1642 | 0.230 |
Why?
|
Zenker Diverticulum | 1 | 2024 | 28 | 0.230 |
Why?
|
Female | 27 | 2025 | 397050 | 0.220 |
Why?
|
Endoscopy, Digestive System | 2 | 2024 | 357 | 0.220 |
Why?
|
Liver Diseases | 2 | 2022 | 1301 | 0.220 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2023 | 46 | 0.220 |
Why?
|
Catheterization | 3 | 2024 | 1431 | 0.220 |
Why?
|
Weight Loss | 4 | 2022 | 2715 | 0.210 |
Why?
|
Monkeypox virus | 1 | 2022 | 43 | 0.210 |
Why?
|
Artificial Intelligence | 4 | 2025 | 2661 | 0.210 |
Why?
|
Aged | 17 | 2025 | 171544 | 0.210 |
Why?
|
Survival Rate | 4 | 2021 | 12870 | 0.200 |
Why?
|
Pancreatic Ducts | 1 | 2024 | 330 | 0.200 |
Why?
|
Cecum | 2 | 2020 | 231 | 0.200 |
Why?
|
Hepatitis A | 1 | 2022 | 127 | 0.200 |
Why?
|
Esophagitis | 1 | 2023 | 164 | 0.200 |
Why?
|
Diverticulum, Esophageal | 1 | 2021 | 14 | 0.200 |
Why?
|
Caregivers | 1 | 2014 | 2303 | 0.200 |
Why?
|
Peptic Ulcer | 1 | 2023 | 222 | 0.190 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2023 | 137 | 0.190 |
Why?
|
Aging | 1 | 2020 | 8764 | 0.190 |
Why?
|
Urban Population | 2 | 2019 | 2045 | 0.190 |
Why?
|
Middle Aged | 18 | 2025 | 223463 | 0.190 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2021 | 54 | 0.180 |
Why?
|
Risk Factors | 11 | 2024 | 74954 | 0.180 |
Why?
|
Helicobacter Infections | 1 | 2024 | 391 | 0.180 |
Why?
|
Lipid Peroxidation | 1 | 2021 | 276 | 0.180 |
Why?
|
Fundoplication | 1 | 2021 | 144 | 0.180 |
Why?
|
Deglutition Disorders | 2 | 2024 | 641 | 0.180 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2021 | 128 | 0.170 |
Why?
|
Fluoroscopy | 1 | 2024 | 952 | 0.170 |
Why?
|
Intestine, Small | 2 | 2025 | 1218 | 0.170 |
Why?
|
Quality-Adjusted Life Years | 2 | 2024 | 1735 | 0.170 |
Why?
|
Physicians | 1 | 2018 | 4614 | 0.170 |
Why?
|
Ileal Neoplasms | 1 | 2019 | 20 | 0.170 |
Why?
|
Vascular Neoplasms | 1 | 2021 | 167 | 0.170 |
Why?
|
Ileocecal Valve | 1 | 2019 | 22 | 0.170 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2021 | 119 | 0.170 |
Why?
|
Pouchitis | 1 | 2020 | 64 | 0.170 |
Why?
|
Capsules | 1 | 2020 | 193 | 0.170 |
Why?
|
Colon, Transverse | 1 | 2019 | 23 | 0.170 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2019 | 33 | 0.170 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59683 | 0.160 |
Why?
|
Hemangiosarcoma | 1 | 2021 | 216 | 0.160 |
Why?
|
Duodenum | 1 | 2022 | 495 | 0.160 |
Why?
|
Gastrointestinal Agents | 1 | 2024 | 510 | 0.160 |
Why?
|
Hygiene | 1 | 2019 | 95 | 0.160 |
Why?
|
Gastric Emptying | 1 | 2021 | 246 | 0.160 |
Why?
|
Cohort Studies | 5 | 2023 | 41791 | 0.150 |
Why?
|
Colectomy | 2 | 2023 | 695 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2023 | 2487 | 0.150 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 81 | 0.150 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2023 | 710 | 0.150 |
Why?
|
Socioeconomic Factors | 2 | 2024 | 7861 | 0.150 |
Why?
|
Connecticut | 1 | 2018 | 365 | 0.150 |
Why?
|
Portal Vein | 1 | 2020 | 431 | 0.150 |
Why?
|
Protein C Deficiency | 1 | 2017 | 25 | 0.140 |
Why?
|
History, 18th Century | 1 | 2018 | 206 | 0.140 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2021 | 526 | 0.140 |
Why?
|
New York City | 1 | 2019 | 737 | 0.140 |
Why?
|
Polycystic Kidney, Autosomal Recessive | 1 | 2017 | 31 | 0.140 |
Why?
|
Gallbladder Neoplasms | 1 | 2018 | 191 | 0.140 |
Why?
|
Drainage | 1 | 2022 | 1183 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2022 | 802 | 0.140 |
Why?
|
Adult | 14 | 2025 | 223622 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 657 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2021 | 584 | 0.130 |
Why?
|
Young Adult | 6 | 2025 | 60048 | 0.130 |
Why?
|
Carcinoma, Papillary | 1 | 2021 | 793 | 0.130 |
Why?
|
Haiti | 1 | 2018 | 553 | 0.130 |
Why?
|
Anastomosis, Surgical | 1 | 2019 | 989 | 0.130 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 434 | 0.130 |
Why?
|
Germany | 1 | 2018 | 882 | 0.130 |
Why?
|
Cystic Fibrosis | 1 | 2025 | 1285 | 0.120 |
Why?
|
History, 19th Century | 1 | 2018 | 715 | 0.120 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1158 | 0.120 |
Why?
|
Mass Screening | 3 | 2022 | 5451 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 684 | 0.120 |
Why?
|
Honduras | 1 | 2014 | 39 | 0.120 |
Why?
|
Lymph Node Excision | 1 | 2021 | 1274 | 0.120 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 664 | 0.120 |
Why?
|
Anticoagulants | 2 | 2023 | 4842 | 0.120 |
Why?
|
Celiac Disease | 1 | 2022 | 820 | 0.120 |
Why?
|
Recurrence | 3 | 2024 | 8501 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 1008 | 0.120 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2018 | 703 | 0.110 |
Why?
|
Diaphragm | 1 | 2015 | 359 | 0.110 |
Why?
|
Cost of Illness | 1 | 2023 | 1959 | 0.110 |
Why?
|
Ghana | 1 | 2014 | 319 | 0.110 |
Why?
|
Moyamoya Disease | 1 | 2017 | 274 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2924 | 0.100 |
Why?
|
Peritoneal Neoplasms | 1 | 2019 | 715 | 0.100 |
Why?
|
Heart Arrest | 1 | 2023 | 1516 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7242 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2023 | 2139 | 0.100 |
Why?
|
Epoxy Compounds | 1 | 2012 | 137 | 0.100 |
Why?
|
Intestinal Mucosa | 2 | 2020 | 3048 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1244 | 0.100 |
Why?
|
Endoribonucleases | 1 | 2013 | 230 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2411 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2050 | 0.090 |
Why?
|
Radiosurgery | 1 | 2021 | 1346 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2023 | 1303 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1317 | 0.090 |
Why?
|
Tendons | 1 | 2015 | 559 | 0.090 |
Why?
|
Laparoscopy | 1 | 2022 | 2034 | 0.090 |
Why?
|
Curriculum | 1 | 2024 | 3775 | 0.090 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2012 | 458 | 0.090 |
Why?
|
Bone Density | 1 | 2023 | 3559 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2771 | 0.090 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3921 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2192 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6541 | 0.080 |
Why?
|
Sex Factors | 2 | 2024 | 10656 | 0.080 |
Why?
|
Prevalence | 2 | 2024 | 15868 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1601 | 0.080 |
Why?
|
Attitude | 1 | 2014 | 772 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 2442 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2021 | 3471 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3431 | 0.080 |
Why?
|
Needles | 2 | 2022 | 461 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2574 | 0.080 |
Why?
|
Length of Stay | 1 | 2023 | 6516 | 0.080 |
Why?
|
Tuberous Sclerosis | 1 | 2017 | 1042 | 0.080 |
Why?
|
Warfarin | 1 | 2017 | 1493 | 0.080 |
Why?
|
Patient Readmission | 1 | 2023 | 3312 | 0.080 |
Why?
|
Proton Pump Inhibitors | 2 | 2024 | 553 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1084 | 0.080 |
Why?
|
India | 1 | 2014 | 2324 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13646 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2021 | 2776 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2542 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2018 | 3520 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3612 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3431 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26373 | 0.070 |
Why?
|
Specimen Handling | 2 | 2022 | 707 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2018 | 3587 | 0.060 |
Why?
|
Obesity | 3 | 2022 | 13082 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3537 | 0.060 |
Why?
|
Ultrasonography, Interventional | 2 | 2024 | 1525 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7458 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1881 | 0.060 |
Why?
|
Capsule Endoscopy | 1 | 2025 | 106 | 0.060 |
Why?
|
Powders | 1 | 2023 | 79 | 0.060 |
Why?
|
Internship and Residency | 1 | 2024 | 5948 | 0.060 |
Why?
|
Adenomatous Polyps | 1 | 2024 | 109 | 0.050 |
Why?
|
Gastroscopy | 1 | 2024 | 213 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Polyps | 1 | 2024 | 200 | 0.050 |
Why?
|
Gels | 1 | 2023 | 421 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Guaiac | 1 | 2022 | 13 | 0.050 |
Why?
|
Poverty | 1 | 2014 | 2721 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18358 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7453 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54921 | 0.050 |
Why?
|
Intestinal Perforation | 1 | 2024 | 253 | 0.050 |
Why?
|
Ascites | 1 | 2024 | 338 | 0.050 |
Why?
|
Esophageal Sphincter, Lower | 1 | 2021 | 26 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10863 | 0.050 |
Why?
|
Medicare | 1 | 2020 | 6881 | 0.050 |
Why?
|
Developing Countries | 1 | 2014 | 2903 | 0.050 |
Why?
|
Suction | 1 | 2023 | 268 | 0.050 |
Why?
|
Child | 3 | 2022 | 80894 | 0.050 |
Why?
|
Pneumothorax | 1 | 2025 | 393 | 0.050 |
Why?
|
Hepatolenticular Degeneration | 1 | 2021 | 73 | 0.050 |
Why?
|
Helicobacter pylori | 1 | 2024 | 381 | 0.050 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 590 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9742 | 0.040 |
Why?
|
Catalytic Domain | 2 | 2013 | 698 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2018 | 11659 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2024 | 418 | 0.040 |
Why?
|
Intestinal Diseases | 1 | 2025 | 505 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10377 | 0.040 |
Why?
|
Gastroscopes | 1 | 2019 | 20 | 0.040 |
Why?
|
Dilatation | 1 | 2021 | 313 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 304 | 0.040 |
Why?
|
Hemochromatosis | 1 | 2021 | 176 | 0.040 |
Why?
|
Probiotics | 1 | 2024 | 383 | 0.040 |
Why?
|
Diet, Gluten-Free | 1 | 2022 | 284 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16716 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4981 | 0.040 |
Why?
|
Appendectomy | 1 | 2023 | 443 | 0.040 |
Why?
|
Minerals | 1 | 2021 | 282 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2024 | 1081 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40267 | 0.040 |
Why?
|
WT1 Proteins | 1 | 2019 | 184 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 168 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13696 | 0.040 |
Why?
|
Remission Induction | 1 | 2024 | 2407 | 0.040 |
Why?
|
Metals | 1 | 2022 | 713 | 0.040 |
Why?
|
RNA-Binding Protein EWS | 1 | 2019 | 211 | 0.040 |
Why?
|
Animals | 2 | 2021 | 169322 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 30230 | 0.030 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2021 | 465 | 0.030 |
Why?
|
Pyrroles | 1 | 2023 | 1126 | 0.030 |
Why?
|
Child, Preschool | 1 | 2020 | 42654 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15652 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2025 | 1207 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 13019 | 0.030 |
Why?
|
Heparin | 1 | 2023 | 1636 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1516 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23629 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1627 | 0.030 |
Why?
|
Learning | 1 | 2024 | 1760 | 0.030 |
Why?
|
Equipment Design | 1 | 2021 | 3529 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1619 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 89182 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1614 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4352 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39405 | 0.020 |
Why?
|
Cadaver | 1 | 2015 | 1366 | 0.020 |
Why?
|
Sepsis | 1 | 2024 | 2601 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4354 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8562 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2013 | 2750 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2013 | 1956 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10117 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5311 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3381 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5337 | 0.020 |
Why?
|
Drug Design | 1 | 2012 | 1046 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18472 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2012 | 3060 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12557 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14736 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2201 | 0.020 |
Why?
|
Binding Sites | 1 | 2012 | 6018 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 30020 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5890 | 0.010 |
Why?
|
Models, Molecular | 1 | 2012 | 5408 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13425 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7063 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17626 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8750 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20766 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 17132 | 0.010 |
Why?
|